Two Sigma Investments’s DICE Therapeutics DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-35,600
Closed -$1.65M – 3377
2023
Q2
$1.65M Buy
35,600
+12,400
+53% +$429K ﹤0.01% 1587
2023
Q1
$665K Sell
23,200
-55,390
-70% -$1.64M ﹤0.01% 2069
2022
Q4
$2.45M Buy
+78,590
New +$2.56M 0.01% 1211

Two Sigma Investments's DICE Position: Q3 2023 in Review

Two Sigma Investments sold out of DICE Therapeutics (DICE) in Q3 2023, closing a stake of 35,600 shares — an estimated $1.65M sold.

Two Sigma Investments first reported a position in DICE in Q4 2022 and held it in 3 quarters. The position peaked at $2.45M in Q4 2022. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Two Sigma Investments reported no remaining DICE Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Investments sold 35,600 DICE Therapeutics shares in Q3 2023, an estimated $1.65M.
  • Two Sigma Investments first reported a position in DICE Therapeutics in Q4 2022 and held it in 3 quarters.
  • Two Sigma Investments's DICE Therapeutics position peaked at $2.45M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics as of Q3 2023.

Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.